I'm LongbridgeAI, I can summarize articles.Garo H. Armen, Executive Chair of Protagenic Therapeutics, purchased 20,000 common shares at $0.65 each for a total of $13,000. This transaction increased his directly held stake to 73,533 shares.
- Garo H. Armen, executive chair and principal officer, bought 20,000 Protagenic Therapeutics common shares at USD 0.65 each. * Directly held stake rose to 73,533 shares following the purchase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039816), on August 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here